comparemela.com

Latest Breaking News On - Guangping gao - Page 1 : comparemela.com

NIIMBL Launches Viral Vector Program to Help Improve Patient Access to AAV Gene Therapy

NEWARK, Del., Oct. 10, 2023 /PRNewswire/ The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) officially launches the Viral Vectors NIIMBL-led Program focused on developing and making broadly available

United-states
Guangping-gao
Eric-hacherl
Mariax-chacon
Tim-charlebois
Viral-vector-program-co
National-institute-for-innovation
Viral-vector-program
Viral-vector-program-steering-committee
National-institute-of-standards
Us-department-of-commerce
University-of-massachusetts-chan-medical-school

NIIMBL Launches Viral Vector Program to Help Improve Patient Access to AAV Gene Therapy

NIIMBL Launches Viral Vector Program to Help Improve Patient Access to AAV Gene Therapy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states
Mariax-chacon
Guangping-gao
Tim-charlebois
Eric-hacherl
University-of-massachusetts-chan-medical-school
Viral-vectors-program
National-institute-for-innovation
Viral-vector-program
Us-department-of-commerce
Viral-vector-program-steering-committee
National-institute-of-standards

Cat contraception using gene therapy could revolutionize animal welfare

Gene therapy produces long-term contraception

For the first time, researchers at Massachusetts General Hospital (MGH), a founding member of Mass General Brigham (MGB), and their collaborators have demonstrated that a single dose of anti-Müllerian hormone (AMH) gene therapy can induce long-term contraception in the domestic cat, potentially providing a safe and effective alternative to surgical spaying.

Boston
Massachusetts
United-states
Cincinnati
Ohio
University-of-massachusetts-medical-school
America
Alya-michelson
Williamf-swanson
Guangping-gao
Philippe-godin
Patriciak-donahoe

Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

TN-201 Received Fast Track Designation from the FDA Dosing Complete in Phase 1 Clinical Trial of TN-301; Data Expected in Second Half 2023 Renowned Researchers Drs. Christine Seidman and Alex Marson. | May 10, 2023

United-states
American
Wendy-ryan
Mark-angelino
Christine-seidman
Angela-thedinga
Christine-edry-seidman
Faraz-ali
Alexander-marson
Guangping-gao
Research-development-rd-expenses
Globenewswire-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.